← SynDRA
V-102862
SynDRA canonical compound SYN0131835 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | SCN2A | SCN4A | SCN9A |
| Mechanism of action | sodium channel blocker |
All known targets
Mechanisms of action (all sources)
- sodium channel blocker
- SCN4A INHIBITOR
- SCN9A INHIBITOR
Cross-references
Synonyms
- CO-102862
- UNII-0KN11H90GF
- CHEMBL287833
- 0KN11H90GF
- 4-(4-fluorophenoxy)benzaldehyde semicarbazone
- (E)-2-(4-(4-fluorophenoxy)benz-ylidene)hydrazinecarboxamide
- V102862
- 2-(4-(4-Fluorophenoxy)benzylidene)hydrazinecarboxamide
- 2-((4-(4-Fluorophenoxy)phenyl)methylene)hydrazinecarboxamide
- 2-[[4-(4-Fluorophenoxy)phenyl]methylene]hydrazinecarboxamide
- Hydrazinecarboxamide, 2-((4-(4-fluorophenoxy)phenyl)methylene)-
- CHEBI:92156
- MolPort-022-863-701
- BDBM50141073
- AKOS016004881
- NCGC00167807-01
- Co-102862
- V 102862
- FPhOBal semicarbazone
- RefChem:918853
- DTXCID8093570
- [(E)-[4-(4-fluorophenoxy)phenyl]methylideneamino]urea
- (E)-2-(4-(4-fluorophenoxy)benzylidene)hydrazinecarboxamide
- MFCD00953614
- orb1305853
- SCHEMBL30320026
- HMS3413N07
- HMS3677N07
- Co102862
- HB1013
- DA-52002
- MS-23875
- HY-108504
- CS-0029016
- T22675
- F986841
- BRD-K08890269-001-01-5
- BRD-K70912147-001-01-8
- CO 102862
Look up V-102862 in the interactive SynDRA portal →